2Armitage JO, Tobinai K, Hoelzer D, et al. Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone. Leuk Lymphoma, 2004,79 (4):311-321.
3Allen IE, Ross SD, Borden SP, et al. Meta- analysis to assess the efficacy of interferon-alpha in patients with follicular non-Hodgkin's lymphoma. J Immunother, 2001,24(1): 58-65.
4Cerny T, Hitz F, Gillessen S. Mabthera-update for treatment of B-cell non Hodgkin lymphoma. Ther Umsch, 2004,61 (6): 379-383.
5Ghobrial I,Witzig T. Radioimmunotherapy: a new treatment modality for B- cell non- Hodgkin's lymphoma. Oncology ( Huntingt ), 2004,18 (5): 623-630.
6Jacobsen E,Freedman A. An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma. Curr Opin Oncol, 2004,16 (2): 106-113.
7Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med, 2002,346(4): 235-242.
8Hemandez L, Bea S, Bellosillo B, et al. Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas:identification of a new TFG- ALK (XL) chimeric gene with transforming activity. Am J Pathol, 2002 , 160 (4): 1487-1494.
9Deconinck E, Lamy T, Foussard C, et al. Autologous stem cell transplantation for anaplastic large- cell lymphomas: results of a prospective trial. Br J Haematol,2000,109(4) :736-742.
10Dierlamm J, Wlodarska I, Michaux L, et al. Genetic abnormalities in marginal zone B- cell lymphoma. Hematol Oncol,2000,18 (1): 1 - 13.
